Pharma

Your Article Summary

See Latest Articles

AVI BioPharma Strengthens Patent Position in Exon Skipping
AVI BioPharma, 11/25/08

AVI BioPharma, Inc., a developer of RNA–based drugs, announced the signing of an exclusive worldwide license agreement with the University of Western Australia (UWA) to a patent application related to the treatment of Duchenne Muscular Dystrophy (DMD).

Today in M&A/Partnerships...keeping you current

Receive free subspecialty "5-minute updates" via email

New graduate degree offered focusing on health care quality
National Committee for Quality Assurance (NCQA), 06/11/09

GSK Signs Deal with Concert Pharma to the Tune of $1 Billion
PharmExec, 06/04/09

Sanofi-aventis and Kyowa Hakko Kirin enter into a Collaboration and Licensing Agreement on an Anti LIGHT fully human monoclonal antibody
Sanofi-aventis, 05/15/09

See All of M&A/Partnerships